Phases

PhasesPhases
Phases

Phases

Phases is building the first full-stack AI agent company to automate clinical trials for pharma companies, starting with patient recruitment.

DR 222025Active3
Rate

About

Phases is developing the first full-stack AI agent platform to automate clinical trials for pharmaceutical companies, initially focusing on the critical bottleneck of patient recruitment. Their AI agent, Polly, helps research sites find, interview, and schedule patients, integrating seamlessly with existing tools. This solution aims to accelerate drug development by addressing the significant delays and costs associated with traditional recruitment methods, which often involve manual record reviews and lengthy screening calls. Phases envisions building a digital workforce for clinical research, allowing teams to concentrate on patient care rather than administrative tasks, ultimately speeding up the delivery of life-saving drugs.
Frequently asked

What does Phases do?

Phases is developing the first full-stack AI agent platform to automate clinical trials for pharmaceutical companies, initially focusing on the critical bottleneck of patient recruitment. Their AI agent, Polly, helps research sites find, interview, and schedule patients, integrating seamlessly with existing tools. This solution aims to accelerate drug development by addressing the significant delays and costs associated with traditional recruitment methods, which often involve manual record revi…

What is Phases's revenue?

StartupHub estimates Phases's annual revenue at $810K (range $658K to $1.0M, 62% confidence), based on comparable companies in the sector.

When was Phases founded?

Phases was founded in 2025.

What industry does Phases operate in?

Phases operates in Agentic AI.

How many employees does Phases have?

Phases has approximately 3 people on record.

HEADCOUNT
3
DOMAIN RATING
22
Comments

No comments yet. Be the first to share your take.